A study of the electroclinic effect in the smectic A* phase of mixtures with strongly chiral alkoxybiphenyl-phenyl carboxylate dopants

A detailed investigation has been reported of the electroclinic behaviour in the smectic A* phase of eleven mixtures made up of a commercial achiral smectic C host and strongly chiral alkoxybiphenyl-phenyl carboxylate dopants. A new technique was used to measure the induced tilt angle as a function of electric field and temperature. For all the mixtures, the electroclinic response followed a Curie-Weiss type temperature dependence for measurements performed well away from the smectic A* to smectic C* phase transition temperature. The strength of the electroclinic response was evaluated for each mixture by determining the temperature independent ratio k/a (i.e. the electroclinic coupling susceptibility, k divided by the susceptibility coefficient controlling the induced tilt, a). Analysis of the results showed that k/a of the mixtures was dependent on the type and position of the electronegative or polar substituents that affected the net dipole moment of the chiral dopants. In fact, the value of k/a was largest when fluorine was replaced by hydrogen in the lateral position and at the chiral centre. Furthermore, relatively short alkyl chains (e.g. C₆H₁₃) at the chiral centre were preferred to longer ones (e.g. C₁₀H₂₁) for a larger electroclinic response.